Published in Adv Neurol on January 01, 2006
Demyelinating optic neuritis in children. J Child Neurol (2008) 0.80
Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis. Arch Neurol (2011) 1.47
Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration. Exp Diabesity Res (2003) 1.04
Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis. Mult Scler (2012) 0.99
Distinct immune regulation of the response to H-2b restricted epitope of MOG causes relapsing-remitting EAE in H-2b/s mice. J Neuroimmunol (2003) 0.92
Myasthenic crisis: guidelines for prevention and treatment. J Neurol Sci (2007) 0.89
Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis. Autoimmun Rev (2013) 0.85
Myasthenia gravis patients, but not healthy subjects, recognize epitopes that are unique to the epsilon-subunit of the acetylcholine receptor. J Neuroimmunol (2004) 0.84
ACTH protects mature oligodendroglia from excitotoxic and inflammation-related damage in vitro. Glia (2013) 0.84
B-cell-activating factor and autoimmune myasthenia gravis. Autoimmune Dis (2011) 0.82
Myasthenia gravis. Curr Treat Options Neurol (2010) 0.81
Adrenocorticotropin hormone 1-39 promotes proliferation and differentiation of oligodendroglial progenitor cells and protects from excitotoxic and inflammation-related damage. J Neurosci Res (2014) 0.80
Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: differential expression of neurotrophic and gliotrophic factors. J Neuroimmunol (2013) 0.80
Cytokines reduce toxic effects of ethanol on oligodendroglia. Neurochem Res (2011) 0.79
Adoptive transfer of myelin basic protein-induced experimental autoimmune encephalomyelitis between SJL and B10.S mice: correlation of priming milieus with susceptibility and resistance phenotypes. J Neuroimmunol (2006) 0.79
Activation of IL-1 signaling pathway in Schwann cells during diabetic neuropathy. Ann N Y Acad Sci (2002) 0.77
The American Academy of Neurology's top five Choosing Wisely recommendations. Neurology (2013) 0.77
Glatiramer acetate in the treatment of multiple sclerosis. Neuropsychiatr Dis Treat (2007) 0.76
"Rebooting" the immune system with cyclophosphamide: taking risks for a "cure"? Ann Neurol (2003) 0.75
The two articles published in the Journal of Neurological Sciences by Dr. Oka. J Neurol Sci (2008) 0.75
At jeopardy: the NIH as we know it. Arch Neurol (2003) 0.75
Approaches to neuroprotective strategies in multiple sclerosis. Expert Opin Pharmacother (2010) 0.75
Farewell editorial. J Neurol Sci (2013) 0.75
Myasthenia gravis. Autoimmune Dis (2012) 0.75
Treatment of patients with multiple sclerosis with anti-herpes virus therapy. Curr Neurol Neurosci Rep (2002) 0.75
Differences between the epsilon and gamma subunits of the acetylcholine receptor (AChR) may be significant in autoimmune myasthenia gravis. Ann N Y Acad Sci (2003) 0.75
The immunopathogenesis of Guillain-Barré syndrome. Clin Adv Hematol Oncol (2010) 0.75
At jeopardy: the NIH as we know it. Neurorehabil Neural Repair (2003) 0.75
Cytokines decrease expression of interleukin-6 signal transducer and leptin receptor in central nervous system glia. J Neurosci Res (2009) 0.75